Reports
Sale
Global Extracorporeal Membrane Oxygenation Market Size, Analysis: By Component: Pumps, Oxygenator, Controllers, Cannula, Accessories; By Modality: Veno-Arterial, Veno-Venous, Arterio-Venous; By Patient Type: Neonates, Pediatric, Adult; By Application: Respiratory, Cardiac, Others; Regional Analysis; Supplier Landscape; 2024-2032
Global Extracorporeal Membrane Oxygenation Market Outlook
The global Extracorporeal Membrane Oxygenation market attained a value of USD 241.67 million in 2023, driven by the increasing prevalence of respiratory and cardiac diseases across the globe. The market size is anticipated to grow at a CAGR of 4.8% during the forecast period of 2024-2032 to achieve a value of USD 368.53 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Pumps Segment to Account for a Significant Market Share of the Global Extracorporeal Membrane Oxygenation Industry
Based on component, the pumps segment is predicted to hold a significant market share in the extracorporeal membrane oxygenation industry. The pumps are an essential element in the ECMO machine that helps pump the blood from the patient's body to the machine and then back. The increased implementation of ECMO machines with the increasing patient population globally is driving the demand for pumps. Moreover, in terms of application, the respiratory segment is estimated to observe a significant growth as a result of the increasing respiratory diseases, especially among the geriatric population, and the rising levels of air pollution in the world. These factors are expected to contribute to the overall market growth in the forecast period.
North America to Occupy a Substantial Market Share in the Global Extracorporeal Membrane Oxygenation Industry
North America is estimated to hold a substantial share of the extracorporeal membrane oxygenation industry in the forecast period. This growth can be attributed to the presence of leading manufacturers of ECMO machines in the region. In addition, the growing geriatric population, susceptible to most cardiopulmonary diseases, is leading to increased investments in ECMO technology by the government and the manufacturers in the region. Furthermore, according to the World Population Report issued by the UN in 2019, the population ageing phenomenon is increasingly being observed worldwide. In North America, particularly, the ratio is expected to rise from 30 persons aged above 65 per 100 people in 2019 to 49 people aged above 65 per 100 people in 2050.
Extracorporeal Membrane Oxygenation: Market Segmentation
Extracorporeal membrane oxygenation (ECMO) refers to a life support machine. It is utilised by patients with severe illnesses that render their heart and lungs unable to function properly. ECMO replaces the functions of the heart and lungs in order to provide oxygen to the patient’s body and help them pump enough blood. The machine is linked to the patient's body with the help of plastic cannulas that pumps blood from the patient's body to an artificial lung, which adds oxygen to it and removes the carbon dioxide, after which the blood is sent back to the patient's body via another pump with the same pressure as the heart. Patients of all ages utilise ECMO during instances of heart and respiratory failure and in the process of cardiopulmonary resuscitation.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By component, the market is divided into:
- Pumps
- Oxygenator
- Controllers
- Cannula
- Accessories
On the basis of modality, the market can be segmented into:
- Veno-Arterial
- Veno-Venous
- Arterio- Venous
Based on patient type, the industry can be categorised into:
- Neonates
- Paediatric
- Adult
On the basis of application, the market can be distributed into:
- Respiratory
- Cardiac
- Extracorporeal Cardiopulmonary Resuscitation (ECPR)
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Heightened Prevalence of Cardiovascular Illnesses and the Rampant Spread of the Covid-19 Infection to Drive the Global Extracorporeal Membrane Oxygenation Industry
According to the WHO, cardiovascular diseases are a leading cause of death globally, with around 17.9 million casualties every year. In addition, most cardiovascular diseases are accompanied by pulmonary ailments such as chronic obstructive pulmonary disease (COPD) and emphysema, among others. In this regard, ECMO machines are widely utilised during the treatment and rehabilitation of patients. Moreover, due to the rampant spread of the Covid-19 virus worldwide, the demand for ECMO machines has increased significantly. These machines are essential in the treatment of patients with severe Covid-19 infection, as their weakened immunity and long-term symptoms make them susceptible to organ failure. These factors are estimated to positively impact the market growth in the forecast period.
Key Industry Players in the Global Extracorporeal Membrane Oxygenation Market
The report gives a detailed analysis of the following key players in the global extracorporeal membrane oxygenation market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Medtronic PLC
- LivaNova PLC
- Terumo Corporation
- MicroPort Scientific Corporation
- Getinge AB
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Component |
|
| Breakup by Modality |
|
| Breakup by Patient Type |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Extracorporeal Membrane Oxygenation Market Overview
3.1 Global Extracorporeal Membrane Oxygenation Market Historical Value (2017-2023)
3.2 Global Extracorporeal Membrane Oxygenation Market Forecast Value (2024-2032)
4 Global Extracorporeal Membrane Oxygenation Market Landscape
4.1 Global Extracorporeal Membrane Oxygenation Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Extracorporeal Membrane Oxygenation Product Landscape
4.2.1 Analysis by Component
4.2.2 Analysis by Modality
4.2.3 Analysis by Patient Type
4.2.4 Analysis by Application
5 Global Extracorporeal Membrane Oxygenation Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Extracorporeal Membrane Oxygenation Market Segmentation
6.1 Global Extracorporeal Membrane Oxygenation Market by Component
6.1.1 Market Overview
6.1.2 Pumps
6.1.3 Oxygenator
6.1.4 Controllers
6.1.5 Cannula
6.1.6 Accessories
6.2 Global Extracorporeal Membrane Oxygenation Market by Modality
6.2.1 Market Overview
6.2.2 Veno-Arterial
6.2.3 Veno-Venous
6.2.4 Arterio-Venous
6.3 Global Extracorporeal Membrane Oxygenation Market by Patient Type
6.3.1 Market Overview
6.3.2 Neonates
6.3.3 Pediatric
6.3.4 Adult
6.4 Global Extracorporeal Membrane Oxygenation Market by Application
6.4.1 Market Overview
6.4.2 Respiratory
6.4.3 Cardiac
6.4.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
6.5 Global Extracorporeal Membrane Oxygenation Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Extracorporeal Membrane Oxygenation Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Extracorporeal Membrane Oxygenation Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Extracorporeal Membrane Oxygenation Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Extracorporeal Membrane Oxygenation Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Extracorporeal Membrane Oxygenation Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Medtronic PLC
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 LivaNova PLC
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Terumo Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 MicroPort Scientific Corporation
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Getinge AB
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Maquet Holding
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medos Medizintechnik
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Nipro Medical Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 CytoSorbents Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 EUROSETS S.R.L
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Extracorporeal Membrane Oxygenation Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
In 2023, the market attained a value of approximately USD 241.67 million.
Over the forecast period of 2024-2032, the market is anticipated to grow at a CAGR of 4.8% to reach USD 368.53 million by 2032.
The major drivers of the industry such as the increased demand for ECMO machine for people suffering from cardiopulmonary diseases, rising geriatric population, steadily increasing patient population globally, and the rapid investments in the research and development of ECMO technology by the leading manufacturers are driving the market growth.
The key market trends guiding the growth of the industry include the increased incidences of COVID-19 infections and heightened prevalence of cardiovascular diseases.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The market is divided based on component into pumps, oxygenator, controllers, cannula, and accessories.
The major segments based on modality include veno-arterial, veno-venous, and arterio-venous.
The significant segments based on patient type include neonates, paediatrics, and adults.
The major application segments include respiratory, cardiac, and extracorporeal cardiopulmonary resuscitation (ECPR).
The major players in the industry are Medtronic PLC, LivaNova PLC, Terumo Corporation, MicroPort Scientific Corporation, and Getinge AB, among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER